Human Dopamine -Hydroxylase Promoter Variant Alters Transcription in Chromaffin Cells, Enzyme Secretion, and Blood Pressure
Author(s) -
Yuhong Chen,
Kai Zhang,
Gen Wen,
F. Rao,
Adriana Paula Sanchez,
Lei Wang,
Juan L. RodriguezFlores,
Manjula Mahata,
Sushil K. Mahata,
Jill Waalen,
Michael G. Ziegler,
Bruce A. Hamilton,
Daniel T. O’Connor
Publication year - 2010
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2010.186
Subject(s) - medicine , dopamine , secretion , blood pressure , endocrinology , enzyme , tyrosine hydroxylase , transcription factor , gene , genetics , biochemistry , biology
Dopamine β-hydroxylase (DBH) plays an indispensable role in catecholamine synthesis by converting dopamine into norepinephrine. Here, we characterized a DBH promoter polymorphism (C-2073T; rs1989787; minor allele frequency ~16%) that influences not only gene transcription but also enzyme secretion and blood pressure (BP) in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom